Registered number
13152494
WAN Pharma Limited
Filleted Accounts
31 January 2025

WAN Pharma Limited
Registered number: | 13152494
Balance Sheet
as at 31 January 2025
Notes |  |  | 2025 |  |  | 2024
£ | £
Fixed assets
Tangible assets | 3 |  |  | 251 |  |  | 204
|  |  |  | 251 |  |  | 204
Current assets
Cash at bank and in hand |  |  | 24,461 |  |  | 26,257
|  |  | 24,461 |  |  | 26,257
Creditors: amounts falling due within one year | 4 |  | (9,100) |  |  | (17,025)
Net current assets |  |  |  | 15,361 |  |  | 9,232
Total assets less current liabilities |  |  |  | 15,612 |  |  | 9,436
Net assets |  |  |  | 15,612 |  |  | 9,436
Capital and reserves
Called up share capital |  |  |  | 100 |  |  | 100
Profit and loss account |  |  |  | 15,512 |  |  | 9,336
Shareholders' funds |  |  |  | 15,612 |  |  | 9,436
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Wajid Ali Nissaar
Director
Approved by the board on 6 January 2026

WAN Pharma Limited
Notes to the Accounts
for the year ended 31 January 2025
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
| Tangible fixed assets
| Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
| Freehold buildings | over 50 years
| Leasehold land and buildings | over the lease term
| Plant and machinery | over 5 years
| Fixtures, fittings, tools and equipment | over 5 years
| Investments
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
| Creditors
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
| Taxation
| A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 | Employees | 2025 |  | 2024
Number | Number
| Average number of persons employed by the company | 1 |  | 0
3 | Tangible fixed assets
|  | Land and buildings |  | Plant and machinery etc |  | Motor vehicles |  | Total
£ | £ | £ | £
| Cost
| At 1 February 2024 | - |  | 399 |  | - |  | 399
| Additions | - |  | 110 |  | - |  | 110
| Surplus on revaluation | - |  | - |  | - |  | -
| Disposals | - |  | - |  | - |  | -
| At 31 January 2025 | - |  | 509 |  | - |  | 509
| Depreciation
| At 1 February 2024 | - |  | 195 |  | - |  | 195
| Charge for the year | - |  | 63 |  | - |  | 63
| Surplus on revaluation | - |  | - |  | - |  | -
| On disposals | - |  | - |  | - |  | -
| At 31 January 2025 | - |  | 258 |  | - |  | 258
| Net book value
| At 31 January 2025 | - |  | 251 |  | - |  | 251
| At 31 January 2024 | - |  | 204 |  | - |  | 204
| Freehold land and buildings: | 2025 |  | 2024
£ | £
| Historical cost | - |  | -
| Cumulative depreciation based on historical cost | - |  | -
|  |  |  |  |  | - |  | -
| [For revalued assets, state the years in which the assets were valued and their values. For assets revalued during the reporting period, state the names of the persons who revalued them or particulars of their qualifications for doing so and the bases of valuation used by them.]
4 | Creditors: amounts falling due within one year | 2025 |  | 2024
£ | £
| Non-equity preference shares | - |  | -
| Bank loans and overdrafts | - |  | -
| Obligations under finance lease and hire purchase contracts | - |  | -
| Trade creditors | - |  | -
| Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | - |  | -
| Taxation and social security costs | 8,500 |  | 8,937
| Other creditors | 600 |  | 8,088
|  |  |  |  |  | 9,100 |  | 17,025
5 | Creditors: amounts falling due after one year | 2025 |  | 2024
£ | £
| Non-equity preference shares | - |  | -
| Bank loans | - |  | -
| Obligations under finance lease and hire purchase contracts | - |  | -
| Trade creditors | - |  | -
| Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | - |  | -
| Other creditors | - |  | -
|  |  |  |  |  | - |  | -

WAN Pharma Limited 13152494 false 2024-02-01 2025-01-31 2025-01-31 VT Final Accounts April 2025 Wajid Ali Nissaar No description of principal activity 13152494 2023-02-01 2024-01-31 13152494 core:WithinOneYear 2024-01-31 13152494 core:ShareCapital 2024-01-31 13152494 core:RetainedEarningsAccumulatedLosses 2024-01-31 13152494 core:AfterOneYear 2024-01-31 13152494 2024-02-01 2025-01-31 13152494 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13152494 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 13152494 bus:Director40 2024-02-01 2025-01-31 13152494 2 2024-02-01 2025-01-31 13152494 core:LandBuildings 2024-02-01 2025-01-31 13152494 core:PlantMachinery 2024-02-01 2025-01-31 13152494 core:Vehicles 2024-02-01 2025-01-31 13152494 bus:FRS102 2024-02-01 2025-01-31 13152494 bus:FilletedAccounts 2024-02-01 2025-01-31 13152494 2025-01-31 13152494 core:WithinOneYear 2025-01-31 13152494 core:ShareCapital 2025-01-31 13152494 core:RetainedEarningsAccumulatedLosses 2025-01-31 13152494 core:LandBuildings 2025-01-31 13152494 core:PlantMachinery 2025-01-31 13152494 core:Vehicles 2025-01-31 13152494 core:AfterOneYear 2025-01-31 13152494 2024-01-31 13152494 core:LandBuildings 2024-01-31 13152494 core:PlantMachinery 2024-01-31 13152494 core:Vehicles 2024-01-31 iso4217:GBP xbrli:pure